As AMH has been shown to inhibit tumor cell proliferation in several gynecological cancers, including ovarian cancer, through AMHR2‐mediated actions, the AMH‐AMHR2 signaling pathway has emerged as a promising therapeutic target for ovarian cancer.15, 16, 17. This evidence concerns the gene AMH and female reproductive organ cancer.